Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025 Biotech Investing
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference Biotech Investing
Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update Biotech Investing
RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD Biotech Investing
Cidara Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for CD388 in Seasonal Influenza Prevention Biotech Investing
Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting Biotech Investing
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress Biotech Investing
Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community Biotech Investing
Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock SmartNews
